Chunmeng Wang

2.2k citations

32 papers · 1.6k indexed · h-index 17

Co-authors: Weidong Han Qingming Yang Yao Wang Yelei Guo Meixia Chen Yang Liu Wenying Zhang Hanren Dai
Topics: CAR-T cell therapy research (17 papers)Lymphoma Diagnosis and Treatment (9 papers)Immune Cell Function and Interaction (7 papers)
Cited by: Oncology Immunology Pathology and Forensic Medicine
Journals: Nucleic Acids Research Journal of Clinical Investigation The Journal of Experimental Medicine
Partner nations: China United States Russia

In The Last Decade

Chunmeng Wang

29 papers receiving 1.6k citations

Peers

Countries citing papers authored by Chunmeng Wang

Since Specialization

Citations

This map shows the geographic impact of Chunmeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunmeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunmeng Wang more than expected).

Fields of papers citing papers by Chunmeng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunmeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunmeng Wang. The network helps show where Chunmeng Wang may publish in the future.

Co-authorship network of co-authors of Chunmeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chunmeng Wang. A scholar is included among the top collaborators of Chunmeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunmeng Wang. Chunmeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison between arm port and chest port: A systematic review and meta-analysis 2025 ·The Journal of Vascular Access ·Jian‐Jun Wei,(unknown),(unknown),Yue Zhang,Chunmeng Wang,Fang He	0
2	Manganese mediates nucleoplasm distribution of cGAS to enhance systemic antitumor immunity and drive abscopal effect 2025 ·Cancer Letters ·Tiance Wang,(unknown),(unknown),Jiejie Liu,Yan Zhang,Chunmeng Wang,(unknown),Meixia Chen,Yulin Jia,Qingming Yang,Zhengfan Jiang,Qian Mei,Weidong Han	0
3	The interim analysis of a first-in-human phase 1 trial of ET-901, a CRISPR edited allogeneic immune-cloaked anti-CD19 CAR-T cell therapy in patients with r/r B-NHL. 2024 ·Journal of Clinical Oncology ·Yang Liu,(unknown),Qingming Yang,Chunmeng Wang,(unknown),Zeguang Wu,(unknown),(unknown),Yuanyuan Qiu,Wei Tang,Haixia Zhang,Zhonghan Yang,(unknown),(unknown),Ming Jin,(unknown),Wensheng Wei,Weidong Han	2
4	IL-6 translation is a therapeutic target of human cytokine release syndrome 2023 ·The Journal of Experimental Medicine ·Yuzhuo Yang,(unknown),(unknown),(unknown),Xin Lin,Yao Wang,(unknown),Chunmeng Wang,Bin Zhang,Weidong Han,Xiaoyu Hu	14
5	Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma 2023 ·Signal Transduction and Targeted Therapy ·Yao Wang,Chuan Tong,Yuting Lu,Zhiqiang Wu,Yelei Guo,Yang Liu,Jianshu Wei,Chunmeng Wang,Qingming Yang,Weidong Han	35
6	Decitabine priming increases anti–PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models 2023 ·Journal of Clinical Investigation ·Xiang Li,Yaru Li,Liang Dong,Yi-Xin Chang,Xingying Zhang,Chunmeng Wang,Meixia Chen,Xiaochen Bo,Hebing Chen,Weidong Han,Jing Nie	47
7	Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy 2023 ·Molecular Cancer ·Zongzhi Liu,(unknown),Yibo Gao,Jiejie Liu,Ya-Ting Feng,Liu Yang,Junyun Wang,Chunmeng Wang,Dongrui Wang,(unknown),Weidong Han,Qian Mei,Yingli Sun	31
8	The mitochondrial‐endoplasmic reticulum co‐transfer in dental pulp stromal cell promotes pulp injury repair 2023 ·Cell Proliferation ·Xiaoyi Zhang,Chunmeng Wang,Z. Y. Zhou,Qi Zhang	8
9	Long‐term complete remission and peripheral biomarkers in Hodgkin lymphoma patients after decitabine‐plus‐camrelizumab epi‐immunotherapy and treatment cessation 2023 ·SHILAP Revista de lepidopterología ·Chunmeng Wang,(unknown),Yang Liu,(unknown),(unknown),Guanghua Rong,(unknown),Zhifang Li,Qingming Yang,Jing Nie,Weidong Han	2
10	Design, synthesis, and anticancer evaluation of ammosamide B with pyrroloquinoline derivatives as novel BRD4 inhibitors 2022 ·Bioorganic Chemistry ·Wen Li,Cheng Zhang,(unknown),(unknown),Jingying Liu,Chunmeng Wang,Min Wang,Yuwei Wang,Chao Wang,Yan Zhang,Lei Shi,Yong Xu,Liping Sun	7
11	Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade Monotherapy 2021 ·Clinical Cancer Research ·Chunmeng Wang,Yang Liu,Liang Dong,Xiang Li,Qingming Yang,Malcolm V. Brock,Qian Mei,Jiejie Liu,Meixia Chen,Fengxia Shi,Miao Liu,Jing Nie,Weidong Han	29
12	Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1–2 trial 2021 ·Leukemia ·(unknown),Yao Wang,Yang Liu,Chuan Tong,Chunmeng Wang,Yelei Guo,Dongdong Ti,Qingming Yang,(unknown),Zhiqiang Wu,Weidong Han	64
13	Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy 2021 ·Journal of Hematology & Oncology ·Chunmeng Wang,Fengxia Shi,Yang Liu,(unknown),(unknown),Xiang Li,Chuan Tong,Yao Wang,(unknown),Jing Nie,Weidong Han	1
14	Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation 2021 ·Frontiers in Cell and Developmental Biology ·Xiang Li,Liang Dong,Jiejie Liu,Chunmeng Wang,Yan Zhang,Qian Mei,Weidong Han,Ping Xie,Jing Nie	10
15	Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia 2020 ·Journal of Hematology & Oncology ·Hanren Dai,Zhiqiang Wu,Hejin Jia,Chuan Tong,Yelei Guo,Dongdong Ti,Han Xiao,Yang Liu,Wenying Zhang,Chunmeng Wang,(unknown),Meixia Chen,Qingming Yang,Yao Wang,Weidong Han	227
16	Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B cell lymphoma 2020 ·Blood ·Chuan Tong,(unknown),Yang Liu,Xingyu Ji,Wenying Zhang,Yelei Guo,Han Xiao,Dongdong Ti,Hanren Dai,Chunmeng Wang,Qingming Yang,Wanli Liu,Yao Wang,Zhiqiang Wu,Weidong Han	202
17	Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy 2018 ·Gene Therapy ·Wenying Zhang,Yang Liu,Yao Wang,Jing Nie,Yelei Guo,Chunmeng Wang,Hanren Dai,Qingming Yang,Zhiqiang Wu,Weidong Han	7
18	Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials 2017 ·Signal Transduction and Targeted Therapy ·Wenying Zhang,Yang Liu,Yao Wang,Chunmeng Wang,Qingming Yang,Hongli Zhu,Weidong Han	16
19	Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial 2016 ·Clinical Cancer Research ·Chunmeng Wang,Zhiqiang Wu,Yao Wang,Yelei Guo,Hanren Dai,Xiaohui Wang,Xiang Li,(unknown),Wenying Zhang,Meixia Chen,Yan Zhang,Kaichao Feng,Yang Liu,Su‐Xia Li,Qingming Yang,Weidong Han	261
20	An LRP16-containing preassembly complex contributes to NF-κB activation induced by DNA double-strand breaks 2015 ·Nucleic Acids Research ·Zhiqiang Wu,Chunmeng Wang,(unknown),Xiaolei Li,Qian Mei,Xiang Li,Yao Wang,Xiaobing Fu,Guangbin Luo,Weidong Han	19

About Chunmeng Wang

Chunmeng Wang is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology, having authored 32 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (17 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (433 citations) and Pathology and Forensic Medicine (249 citations). Chunmeng Wang has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Weidong Han, Qingming Yang, Yao Wang, Yelei Guo, Meixia Chen, Yang Liu, Wenying Zhang, Hanren Dai, Zhiqiang Wu and Chuan Tong. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact